TECTONIC THERAPEUTIC, INC. Financing Cash Flow
TECTONIC THERAPEUTIC, INC. (TECX) reported Financing Cash Flow of $12.53 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- TECTONIC THERAPEUTIC, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $11.68M.
- TECTONIC THERAPEUTIC, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $847.00K, a 99.52% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$141.00K.
- TECTONIC THERAPEUTIC, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$457.00K.
- TECTONIC THERAPEUTIC, INC. net cash provided by (used in) financing activities for fiscal 2025 was $173.35M, a 0.96% increase from fiscal 2024.
- TECTONIC THERAPEUTIC, INC. net cash provided by (used in) financing activities for fiscal 2024 was $171.71M, a 408.83% increase from fiscal 2023.
- TECTONIC THERAPEUTIC, INC. net cash provided by (used in) financing activities for fiscal 2023 was $33.75M, a 12780.53% increase from fiscal 2022.
- TECTONIC THERAPEUTIC, INC. net cash provided by (used in) financing activities for fiscal 2022 was $262.00K, a 99.14% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $11.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $12.53M 10-Q · filed 2026-08-06 | $12.39M derived: sum of 3 quarters · filed 2026-08-06 | $11.93M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $847.00K 10-Q · filed 2026-05-07 | $706.00K derived: sum of 2 quarters · filed 2026-05-07 | $249.00K derived: sum of 3 quarters · filed 2026-05-07 | -$3.92M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$598.00K derived: sum of 2 quarters · filed 2026-02-26 | -$4.77M derived: sum of 3 quarters · filed 2026-08-06 | $173.35M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | -$457.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$4.63M derived: sum of 2 quarters · filed 2026-08-06 | $173.50M 10-Q · filed 2025-11-06 | $172.43M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$4.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $173.95M 10-Q · filed 2026-08-06 | $172.88M derived: sum of 3 quarters · filed 2026-08-06 | $166.60M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $178.12M 10-Q · filed 2026-05-07 | $177.05M derived: sum of 2 quarters · filed 2026-05-07 | $170.77M derived: sum of 3 quarters · filed 2026-05-07 | $350.50M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$7.36M derived: sum of 2 quarters · filed 2026-02-26 | $172.38M derived: sum of 3 quarters · filed 2026-02-26 | $171.71M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | -$6.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $173.45M derived: sum of 2 quarters · filed 2025-11-06 | $172.78M 10-Q · filed 2025-11-06 | $206.91M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | $179.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $179.07M 10-Q · filed 2025-08-07 | $213.20M derived: sum of 3 quarters · filed 2025-08-07 | $213.09M derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | -$668.00K 10-Q · filed 2025-05-08 | $30.00K 10-Q · filed 2024-05-09 | $33.46M derived: sum of 2 quarters · filed 2025-05-08 | $33.35M derived: sum of 3 quarters · filed 2025-05-08 | $33.02M derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | $34.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $34.02M derived: sum of 2 quarters · filed 2025-03-20 | $33.69M derived: sum of 3 quarters · filed 2025-03-20 | $33.75M 10-K · filed 2025-03-20 | -$16.03M 10-K · filed 2024-03-14 | |||
| 2023-09-30 | -$114.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$438.00K derived: sum of 2 quarters · filed 2024-11-12 | -$383.00K 10-Q · filed 2024-11-12 | -$16.09M 10-Q · filed 2023-11-09 | -$324.00K derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | -$324.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$269.00K 10-Q · filed 2024-08-14 | -$16.27M 10-Q · filed 2023-08-10 | -$210.00K derived: sum of 3 quarters · filed 2024-08-14 | -$150.00K derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | $55.00K 10-Q · filed 2024-05-09 | $114.00K derived: sum of 2 quarters · filed 2024-05-09 | $174.00K derived: sum of 3 quarters · filed 2024-05-09 | $175.00K derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $119.00K derived: sum of 2 quarters · filed 2024-03-14 | $120.00K derived: sum of 3 quarters · filed 2024-03-14 | $262.00K 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | $60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $61.00K derived: sum of 2 quarters · filed 2023-11-09 | $203.00K 10-Q · filed 2023-11-09 | $15.15M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $143.00K 10-Q · filed 2023-08-10 | $15.09M derived: sum of 3 quarters · filed 2023-08-10 | $15.11M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $142.00K 10-Q · filed 2023-05-11 | $15.09M derived: sum of 2 quarters · filed 2023-05-11 | $15.11M derived: sum of 3 quarters · filed 2023-05-11 | $29.71M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $14.95M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $14.97M derived: sum of 2 quarters · filed 2023-03-23 | $29.57M derived: sum of 3 quarters · filed 2023-03-23 | $30.37M 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | $22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $14.63M derived: sum of 2 quarters · filed 2022-11-08 | $15.43M 10-Q · filed 2022-11-08 | $86.13M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $14.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $15.40M 10-Q · filed 2022-08-09 | $86.11M derived: sum of 3 quarters · filed 2022-08-09 | $86.17M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | $799.00K 10-Q · filed 2022-05-10 | $71.50M derived: sum of 2 quarters · filed 2022-05-10 | $71.56M derived: sum of 3 quarters · filed 2022-05-10 | $79.75M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $70.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $70.77M derived: sum of 2 quarters · filed 2022-03-17 | $78.96M derived: sum of 3 quarters · filed 2022-03-17 | $172.62M 10-K · filed 2022-03-17 | ||||
| 2020-09-30 | $60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $8.25M derived: sum of 2 quarters · filed 2021-11-04 | $101.91M 10-Q · filed 2021-11-04 | $101.94M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $8.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $101.85M 10-Q · filed 2021-08-05 | $101.88M derived: sum of 3 quarters · filed 2021-08-05 | $231.36M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $93.66M 10-Q · filed 2021-05-13 | $93.69M derived: sum of 2 quarters · filed 2021-05-13 | $223.17M derived: sum of 3 quarters · filed 2021-05-13 | $223.41M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $129.50M derived: sum of 2 quarters · filed 2021-03-18 | $129.74M derived: sum of 3 quarters · filed 2021-03-18 | $129.99M 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | $129.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $129.71M derived: sum of 2 quarters · filed 2020-11-05 | $129.96M 10-Q · filed 2020-11-05 | $129.82M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $238.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $490.00K 10-Q · filed 2020-08-06 | $351.00K derived: sum of 3 quarters · filed 2020-08-06 | -$2.90M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $252.00K 10-Q · filed 2020-05-07 | $113.00K derived: sum of 2 quarters · filed 2020-05-07 | -$3.14M derived: sum of 3 quarters · filed 2020-05-07 | $102.33M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | -$139.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$3.39M derived: sum of 2 quarters · filed 2020-03-16 | $102.08M derived: sum of 3 quarters · filed 2020-03-16 | $160.29M 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | -$3.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $102.22M derived: sum of 2 quarters · filed 2019-11-07 | $160.43M 10-Q · filed 2019-11-07 | $174.39M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | $105.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $163.68M 10-Q · filed 2019-08-08 | $177.65M derived: sum of 3 quarters · filed 2019-08-08 | $177.62M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $58.21M 10-Q · filed 2019-05-13 | $72.17M derived: sum of 2 quarters · filed 2019-05-13 | $72.14M derived: sum of 3 quarters · filed 2019-05-13 | |||||
| 2017-12-31 | $13.97M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | $13.94M derived: sum of 2 quarters · filed 2019-03-25 | $17.37M 10-K · filed 2019-03-25 | |||||
| 2017-09-30 | -$32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $3.40M 10-Q · filed 2018-11-13 | ||||||
| 2017-06-30 | $3.44M 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |